SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+12.43%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$565M
AUM Growth
+$565M
(-13%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-22.21%
Top 10 Holdings %
Top 10 Hldgs %
37.05%
Holding
162
New
40
Increased
21
Reduced
46
Closed
39
Top Buys
| 1 |
Gilead Sciences
GILD
|
$17.9M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$15.9M |
| 3 |
Biogen
BIIB
|
$13.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$8.86M |
| 5 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$6.96M |
Top Sells
| 1 |
Merck
MRK
|
$24.8M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$23M |
| 4 |
Johnson & Johnson
JNJ
|
$22.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$14.4M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 5.3% |
| 3 | Industrials | 3.85% |
| 4 | Energy | 1.97% |
| 5 | Consumer Discretionary | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PTC Therapeutics
PTCT
$4.41B
| $5.7M | 0.97% |
110,000
+46,375
| +73% | +$2.4M |
|
27
Viatris
VTRS
$12.3B
| $5.47M | 0.93% |
97,100
| – | – |
|
|
AMAG
28
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $5.34M | 0.91% |
125,230
-25,000
| -17% | -$1.07M |
|
|
MDVN
29
DELISTED
MEDIVATION, INC.
MDVN
| $5.29M | 0.9% |
53,115
-10,000
| -16% | -$996K |
|
30
Vanda Pharmaceuticals
VNDA
$279M
| $5.28M | 0.9% |
368,390
+150,000
| +69% | +$2.15M |
|
31
Financial Select Sector SPDR Fund
XLF
$53.6B
| $5.19M | 0.88% |
+210,000
| New | +$5.19M |
|
|
TW
32
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $4.79M | 0.82% |
42,350
+14,350
| +51% | +$1.62M |
|
33
TJX Companies
TJX
$155B
| $4.64M | 0.79% |
67,630
+40,030
| +145% | +$2.75M |
|
|
ARRY
34
DELISTED
Array Biopharma Inc
ARRY
| $4.61M | 0.78% |
973,922
+100,000
| +11% | +$473K |
|
|
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.59M | 0.78% |
81,955
-20,000
| -20% | -$1.12M |
|
36
Amicus Therapeutics
FOLD
$2.42B
| $4.58M | 0.78% |
+550,000
| New | +$4.58M |
|
|
DYAX
37
DELISTED
DYAX CORPORATION
DYAX
| $4.47M | 0.76% |
317,556
-200,000
| -39% | -$2.81M |
|
38
GSK
GSK
$79.3B
| $4.2M | 0.72% |
98,200
+1,100
| +1% | +$47K |
|
|
FWP
39
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $4.17M | 0.71% |
+200,000
| New | +$4.17M |
|
|
ORBK
40
DELISTED
Orbotech Ltd
ORBK
| $4.16M | 0.71% |
280,872
-290,660
| -51% | -$4.3M |
|
41
Cytokinetics
CYTK
$5.98B
| $3.95M | 0.67% |
493,212
+130,000
| +36% | +$1.04M |
|
|
RLYP
42
DELISTED
RELYPSA INC COM
RLYP
| $3.92M | 0.67% |
127,100
+30,000
| +31% | +$924K |
|
|
BRCM
43
DELISTED
BROADCOM CORP CL-A
BRCM
| $3.85M | 0.66% |
88,800
-10,560
| -11% | -$458K |
|
44
Puma Biotechnology
PBYI
$258M
| $3.84M | 0.65% |
20,296
-10,000
| -33% | -$1.89M |
|
|
CBAY
45
DELISTED
Cymabay Therapeutics
CBAY
| $3.84M | 0.65% |
390,355
-100,000
| -20% | -$983K |
|
46
Ituran Location and Control
ITRN
$653M
| $3.71M | 0.63% |
168,203
-62,912
| -27% | -$1.39M |
|
|
RCPT
47
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.68M | 0.63% |
30,000
+5,000
| +20% | +$613K |
|
48
Vertex Pharmaceuticals
VRTX
$102B
| $3.56M | 0.61% |
30,000
-120,000
| -80% | -$14.3M |
|
49
CVS Health
CVS
$93B
| $3.53M | 0.6% |
36,610
-3,200
| -8% | -$308K |
|
|
AGTC
50
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.47M | 0.59% |
165,124
-45,600
| -22% | -$959K |
|